ERIKA SIMON: Open Payments
NPI 1770255317 · OAKHURST, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,697 in 89 payments from 13 companies in 2025. Trend: 2023 $141 · 2024 $941 · 2025 $1,697
Food & beverage: $1,697
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 32 | $616 |
| ABBVIE INC. | 19 | $316 |
| AstraZeneca Pharmaceuticals LP | 11 | $290 |
| Amgen Inc. | 9 | $151 |
| Lilly USA, LLC | 5 | $86 |
| Merck Sharp & Dohme LLC | 3 | $56 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| PFIZER INC. | 2 | $32 |
| Exact Sciences Corporation | 1 | $24 |
Products named: Ozempic, Wegovy, QULIPTA, BREZTRI, EVENITY, VRAYLAR, MOUNJARO, AIRSUPRA.
Industry payments across NJ — which companies pay providers there.
